Literature DB >> 29249383

Neuropathic pain and SCI: Identification and treatment strategies in the 21st century.

Maya N Hatch1, Timothy R Cushing2, Gregory D Carlson3, Eric Y Chang4.   

Abstract

Pain is a common complication in patients following spinal cord injury (SCI), with studies citing up to 80% of patients reporting some form of pain. Neuropathic pain (NP) makes up a substantial percentage of all pain symptoms in patients with SCI and is often complex. Given the high prevalence of NP in patients with SCI, proper identification and treatment is imperative. Indeed, identification of pain subtypes is a vital step toward determining appropriate treatment. A variety of pharmacological and non-pharmacological treatments can be undertaken including antiepileptics, tricyclic antidepressants, opioids, transcranial direct current stimulation, and invasive surgical procedures. Despite all the available treatment options and advances in the field of SCI medicine, providing adequate treatment of NP after SCI continues to be challenging. It is therefore extremely important for clinicians to have a strong foundation in the identification of SCI NP, as well as an understanding of appropriate treatment options. Here, we highlight the definitions and classification tools available for NP identification, and discuss current treatment options. We hope that this will not only provide a better understanding of NP for physicians in various subspecialties, but that it will also help guide future research on this subject.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ISCIP; Neuropathic pain; Neuropathic pain measures; Pain classification; Pain management; SCI pain treatment; Spinal cord injury

Mesh:

Year:  2017        PMID: 29249383     DOI: 10.1016/j.jns.2017.11.018

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  24 in total

1.  Hellenic Spinal Cord Section of the Hellenic Society of Physical and Rehabilitation Medicine National Congress 2019, "Healthy, and long living after SCI" Proceedings. 13th-15th December 2019, Vellideio, Thessaloniki, Greece.

Authors: 
Journal:  J Musculoskelet Neuronal Interact       Date:  2019-12-01       Impact factor: 2.041

2.  The demographics of pain after spinal cord injury: a survey of our model system.

Authors:  James J Bresnahan; Benjamin R Scoblionko; Devon Zorn; Daniel E Graves; Eugene R Viscusi
Journal:  Spinal Cord Ser Cases       Date:  2022-01-28

3.  Long-term clinical observation of patients with acute and chronic complete spinal cord injury after transplantation of NeuroRegen scaffold.

Authors:  Fengwu Tang; Jiaguang Tang; Yannan Zhao; Jiaojiao Zhang; Zhifeng Xiao; Bing Chen; Guang Han; Na Yin; Xianfeng Jiang; Changyu Zhao; Shixiang Cheng; Ziqiang Wang; Yumei Chen; Qiaoling Chen; Keran Song; Zhiwei Zhang; Junjie Niu; Lingjun Wang; Qin Shi; Liang Chen; Huilin Yang; Shuxun Hou; Sai Zhang; Jianwu Dai
Journal:  Sci China Life Sci       Date:  2021-08-16       Impact factor: 6.038

4.  Pharmacologic therapies of pain in patients with spinal cord injury: a systematic review.

Authors:  Mohammad Hossein Asgardoon; Seyed Behnam Jazayeri; Atefeh Behkar; Mohammad Amin Dabbagh Ohadi; Hossein Yarmohammadi; Zahra Ghodsi; Tommaso Ivan Pomerani; Mojtaba Mojtahedzadeh; Vafa Rahimi-Movaghar
Journal:  Spinal Cord Ser Cases       Date:  2022-07-04

5.  Future Treatment of Neuropathic Pain in Spinal Cord Injury: The Challenges of Nanomedicine, Supplements or Opportunities?

Authors:  Giuseppe Forte; Valentina Giuffrida; Angelica Scuderi; Mariella Pazzaglia
Journal:  Biomedicines       Date:  2022-06-10

Review 6.  Recent advances in nanoplatforms for the treatment of neuropathic pain.

Authors:  Beibei Yu; Kunzhe Wu; Xiaohua Xu; Yan Liu; Jinlan Jiang
Journal:  Spinal Cord       Date:  2022-01-27       Impact factor: 2.473

Review 7.  Central Neuropathic Pain Syndromes: Current and Emerging Pharmacological Strategies.

Authors:  Katharine N Gurba; Rida Chaudhry; Simon Haroutounian
Journal:  CNS Drugs       Date:  2022-05-05       Impact factor: 6.497

8.  Ferroptosis is involved in the development of neuropathic pain and allodynia.

Authors:  Huixing Wang; Xiaodong Huo; Chenyang Han; Jiang Ning; Hongguang Chen; Bo Li; Jingzhi Liu; Wenting Ma; Quanbo Li; Yonghao Yu; Kemei Shi
Journal:  Mol Cell Biochem       Date:  2021-04-17       Impact factor: 3.396

9.  Treatment-Induced Neuropathy in Diabetes (TIND)-Developing a Disease Model in Type 1 Diabetic Rats.

Authors:  Petra Baum; Severin Koj; Nora Klöting; Matthias Blüher; Joseph Classen; Sabine Paeschke; Martin Gericke; Klaus V Toyka; Marcin Nowicki; Joanna Kosacka
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

Review 10.  Botulinum Toxin Type A-A Modulator of Spinal Neuron-Glia Interactions under Neuropathic Pain Conditions.

Authors:  Ewelina Rojewska; Anna Piotrowska; Katarzyna Popiolek-Barczyk; Joanna Mika
Journal:  Toxins (Basel)       Date:  2018-04-02       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.